Table 3.
Results of Univariate and Multivariate Linear Regression Analyses Assessing Associations Between the baPWV Measured at Baseline and the PEP/ET Ratio and NT-proBNP Concentrations Measured at Baseline and at the End of the Study Period
| Outcome variable | Crude | AdjustedA | ||||||
|---|---|---|---|---|---|---|---|---|
| Total R2
(×10−1) |
Standardized coefficient (×10−1) |
Non-standardized coefficient (×10−1; 95% CI) |
P value | Total R2
(×10−1) |
Standardized coefficient (×10−1) |
Non-standardized coefficient (×10−1; 95% CI) |
P value | |
| PEP/ET ratio | ||||||||
| At baseline | 1.0 | 3.0 | 0.08 (0.07–0.1) | <0.01 | 1.7 | 2.9 | 0.8 (0.6–0.9) | <0.01 |
| At the end of the study | 0.3 | 1.8 | 0.05 (0.04–0.06) | <0.01 | 1.0 | 1.1 | 0.03 (0.02–0.04) | <0.01 |
| Log [NT-proBNP] | ||||||||
| At baseline | 0.2 | 0.1 | 0.6 (0.4–0.8) | <0.01 | 1.7 | – | – | 0.51 |
| At the end of the study | 0.3 | 1.8 | 0.7 (0.5–0.9) | <0.01 | 0.1 | – | – | 0.53 |
AAdjusted for age, BMI, SBP, heart rate, HbA1c, serum LDL-C, current smoking, amount of drinking, and past medical history of hyperuricemia at baseline. Abbreviations as in Tables 1,2.